ReP USP - Resultado da busca

Artigo de periodico
Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study (2013)
Kreimer, Aimée R.; Campbell, Christine M. Pierce; Lin, Hui-Yi; Fulp, William; Papenfuss, Mary R.; Abrahamsen, Martha; Hildesheim, Allan; Villa, Luisa L.; Salmerón, Jorge J.; Lazcano-Ponce, Eduardo; Giuliano, Anna R.
Source: Lancet. Unidade: FM
Subjects: PAPILOMA BUCAL, PAPILLOMAVIRUS, ESTUDOS DE COORTES, HOMENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KREIMER, Aimée R. et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet, v. 382, n. 9895, p. 877-887, 2013Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(13)60809-0. Acesso em: 08 nov. 2024.
APA
Kreimer, A. R., Campbell, C. M. P., Lin, H. -Y., Fulp, W., Papenfuss, M. R., Abrahamsen, M., et al. (2013). Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet, 382( 9895), 877-887. doi:10.1016/S0140-6736(13)60809-0
NLM
Kreimer AR, Campbell CMP, Lin H-Y, Fulp W, Papenfuss MR, Abrahamsen M, Hildesheim A, Villa LL, Salmerón JJ, Lazcano-Ponce E, Giuliano AR. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study [Internet]. Lancet. 2013 ; 382( 9895): 877-887.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(13)60809-0
Vancouver
Kreimer AR, Campbell CMP, Lin H-Y, Fulp W, Papenfuss MR, Abrahamsen M, Hildesheim A, Villa LL, Salmerón JJ, Lazcano-Ponce E, Giuliano AR. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study [Internet]. Lancet. 2013 ; 382( 9895): 877-887.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(13)60809-0
Artigo de periodico
Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial (2013)
Wiviott, Stephen D.; White, Harvey D.; Ohman, E. Magnus; Fox, Keith A. A.; Armstrong, Paul W.; Prabhakaran, Dorairaj; Hafley, Gail Yuliya Lokhnygina; Lokhnygina, Yuliya; Boden, William E.; Hamm, Christian; Clemmensen, Peter; Nicolau, Jose C.; Menozzi, Alberto; Ruzyllo, Witold; Widimsky, Petr; Oto, Ali; Leiva-Pons, Jose; Pavlides, Gregory; Winters, Kenneth J.; Roe, Matthew T.; Bhatt, Deepak L.
Source: Lancet. Unidade: FM
Subjects: ANGINA INSTÁVEL, INFARTO DO MIOCÁRDIO, ANGIOGRAFIA, CORONORAIOPATIA, DOENÇAS CARDIOVASCULARES (MORTALIDADE), REVASCULARIZAÇÃO MIOCÁRDICA (COMPLICAÇÕES)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WIVIOTT, Stephen D. et al. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet, v. 382, n. 9892, p. 605-613, 2013Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(13)61451-8. Acesso em: 08 nov. 2024.
APA
Wiviott, S. D., White, H. D., Ohman, E. M., Fox, K. A. A., Armstrong, P. W., Prabhakaran, D., et al. (2013). Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet, 382( 9892), 605-613. doi:10.1016/S0140-6736(13)61451-8
NLM
Wiviott SD, White HD, Ohman EM, Fox KAA, Armstrong PW, Prabhakaran D, Hafley GYL, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzyllo W, Widimsky P, Oto A, Leiva-Pons J, Pavlides G, Winters KJ, Roe MT, Bhatt DL. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial [Internet]. Lancet. 2013 ; 382( 9892): 605-613.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(13)61451-8
Vancouver
Wiviott SD, White HD, Ohman EM, Fox KAA, Armstrong PW, Prabhakaran D, Hafley GYL, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzyllo W, Widimsky P, Oto A, Leiva-Pons J, Pavlides G, Winters KJ, Roe MT, Bhatt DL. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial [Internet]. Lancet. 2013 ; 382( 9892): 605-613.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(13)61451-8
Artigo de periodico-carta/editorial
Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta] (2013)
Santos, Raul D.
Source: Lancet. Unidade: FM
Subjects: FATORES DE RISCO, LIPÍDEOS, DOENÇAS CARDIOVASCULARES (GENÉTICA), HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D. Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0140-6736(13)60797-7. Acesso em: 08 nov. 2024. , 2013
APA
Santos, R. D. (2013). Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0140-6736(13)60797-7
NLM
Santos RD. Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta] [Internet]. Lancet. 2013 ; 381( 9873): 1182.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(13)60797-7
Vancouver
Santos RD. Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta] [Internet]. Lancet. 2013 ; 381( 9873): 1182.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(13)60797-7

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em